(Q34620485)

3 August 2017

1 reference

title

Dapoxetine for premature ejaculation. (English)

1 reference

3 August 2017

main subject

premature ejaculation

1 reference

Chris G McMahon

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Expert Opinion on Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

volume

11

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

1741-1752

1 reference

Sexological approach to ejaculatory dysfunction

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Animal models of ejaculatory behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation: a psychophysiological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

How does premature ejaculation impact a man s life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

A multinational population survey of intravaginal ejaculation latency time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation: an observational study of men and their partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation: results from a five-country European observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

An analysis of self-reported sexual behavior in a sample of normal males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

The prevalence and perceived aetiology of male sexual problems in a non-clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

The relationships among ejaculatory control, ejaculatory latency, and attempts to prolong heterosexual intercourse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Sexual dysfunction in the United States: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Prevalence of chronic prostatitis in men with premature ejaculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation associated with citalopram withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Alcohol, drugs and sexual function: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Synthesis of [11C]dapoxetine.HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Effect of acute dapoxetine administration on the pudendal motoneuron reflex in anesthetized rats: comparison with paroxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature or rapid ejaculation: heterosexual couples' perceptions of men's ejaculatory behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation: a psychophysiological approach for assessment and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Serotonin reuptake inhibitor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Selective serotonin reuptake inhibitor discontinuation syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

ACNP Task Force report on SSRIs and suicidal behavior in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

SSRI discontinuation syndrome. Awareness as an approach to prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation: definition and drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Effect of dapoxetine on the pharmacokinetics and hemodynamic effects of tamsulosin in men on a stable dose of tamsulosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

Off-label prescribing among office-based physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.493174

10.1517/14656566.2010.493174

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference